Exonate announces successful completion of Phase Ib/IIa trial in diabetic macular oedema
Lead ophthalmology candidate EXN407 has potential to be the first topical treatment for diabetic retinopathy/diabetic macular oedema.
Stay updated with breaking news from Ascular. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Lead ophthalmology candidate EXN407 has potential to be the first topical treatment for diabetic retinopathy/diabetic macular oedema.
During missions into space, astronauts are exposed to high levels of galactic cosmic radiation and weightlessness.
Researchers compare the trends in cardiovascular disease-related mortality among patients with Alzheimer’s disease with general United States population.
Knee operations on the meniscus cartilage are a frequent procedure on a particularly complex part of the human body.
The effectiveness of magnetic anastomosis technology (MAT) in Liver Transplantation.